News & Analysis as of

Tariffs Inflation Reduction Act (IRA) Regulatory Reform

Vinson & Elkins LLP

Summer 2025 V&E Quarterly Governance and Sustainability Updates

Vinson & Elkins LLP on

We have seen, a mere few months into President Trump’s second term, a remarkably transformational set of priorities across the federal government, which have had dramatic impacts on the private sector generally and public...more

Faegre Drinker Biddle & Reath LLP

The Effects of HHS Workforce Reductions, Tariffs on Pharma, the ‘Pill Penalty’ and More

With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices. In this briefing, we highlight recent regulatory and legislative developments...more

Latham & Watkins LLP

Healthcare Life Sciences Drug Pricing Digest - April 2025 #2

Latham & Watkins LLP on

On April 15, 2025, President Trump signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The order includes various provisions that are relevant to the pharmaceutical industry,...more

Ankura

Navigating Change: The Impact of the Trump Administration on the U.S. Construction Industry

Ankura on

In the wake of the recent U.S. presidential administration transition, the construction industry is poised to experience significant shifts. As the Trump administration takes office, industry leaders and stakeholders should...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide